Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immune Thrombocytopenia (Itp) in a Patient With Relapsing-Remitting Multiple Sclerosis (Rrms) Associated With B-Interferon-1Α Treatment Publisher



Shaygannejad V1, 2 ; Fayyazi E1 ; Mirmosayyeb O1 ; Toghianifar N1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Non-communicable Disease Unit, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Indian Journal of Pharmaceutical Education and Research Published:2018


Abstract

This paper reports a case of severe immunethrombocytopenia (ITP) associated with b-interferon-1α (Cinnovex) in a patient with relapsing remitting multiples clerosis (RRMS). A 22 year old woman with a one-year history of RRMS referred to MS Clinic due to purpuricrash. The platelet count was 6,000/μL at admission.A diagnosis ITP was made. Cinnovex was stopped. She received intravenous methylprednisolone 500mg/d, for2days, and intravenous immungloboulin (IVIG), 55mg.Thrombocytopeniare solved in the following days. She was started on CinnoMer (GlatiramerAcetate, CinnaGenCo.) for MSmanagement.There was no recurrence of thrombocytopenia in the next follow-up visits. © 2018, Association of Pharmaceutical Teachers of India. All rights reserved.